世界の移行上皮がん治療薬市場：市場規模・現状・予測

• 英文タイトル：Global Transitional Cell Cancer Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N8141
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、移行上皮がん治療薬のグローバル市場について調査・分析したレポートで、種類別（膀胱腫瘍の経尿道的切除、膀胱切除術、尿路変更）、用途別（病院、がん研究所、多専門クリニック、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・移行上皮がん治療薬の世界市場規模
・主要企業別市場シェア
・移行上皮がん治療薬の世界市場規模：種類別（膀胱腫瘍の経尿道的切除、膀胱切除術、尿路変更）
・移行上皮がん治療薬の世界市場規模：用途別（病院、がん研究所、多専門クリニック、外来手術センター）
・移行上皮がん治療薬のアメリカ市場規模（種類別、用途別）
・移行上皮がん治療薬のヨーロッパ市場規模（種類別、用途別）
・移行上皮がん治療薬の中国市場規模（種類別、用途別）
・移行上皮がん治療薬の日本市場規模（種類別、用途別）
・移行上皮がん治療薬の東南アジア市場規模（種類別、用途別）
・移行上皮がん治療薬のインド市場規模（種類別、用途別）
・移行上皮がん治療薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・移行上皮がん治療薬の世界市場予測（2019年-2025年）
・移行上皮がん治療薬の地域別市場予測（2019年-2025年）
...

Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra.Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking.
In 2018, the global Transitional Cell Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Transitional Cell Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transitional Cell Cancer Therapeutics development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Roche
Bristol-Myers Squibb
Pfizer
Exelixis
Eisai
Merck
Eli Lilly
Celgene

Market segment by Type, the product can be split into
Transurethral Resection Of Bladder Tumor
Cystectomy
Urinary Diversion

Market segment by Application, split into
Hospital
Cancer Research Institutes
Multispecialty Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Transitional Cell Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Transitional Cell Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Transitional Cell Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Transitional Cell Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Transurethral Resection Of Bladder Tumor
1.4.3 Cystectomy
1.4.4 Urinary Diversion
1.5 Market by Application
1.5.1 Global Transitional Cell Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Cancer Research Institutes
1.5.4 Multispecialty Clinics
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Transitional Cell Cancer Therapeutics Market Size
2.2 Transitional Cell Cancer Therapeutics Growth Trends by Regions
2.2.1 Transitional Cell Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Transitional Cell Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Transitional Cell Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Transitional Cell Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Transitional Cell Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Transitional Cell Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Transitional Cell Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Transitional Cell Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Transitional Cell Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Transitional Cell Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Transitional Cell Cancer Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Transitional Cell Cancer Therapeutics Market Size (2014-2019)
5.2 Transitional Cell Cancer Therapeutics Key Players in United States
5.3 United States Transitional Cell Cancer Therapeutics Market Size by Type
5.4 United States Transitional Cell Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Transitional Cell Cancer Therapeutics Market Size (2014-2019)
6.2 Transitional Cell Cancer Therapeutics Key Players in Europe
6.3 Europe Transitional Cell Cancer Therapeutics Market Size by Type
6.4 Europe Transitional Cell Cancer Therapeutics Market Size by Application

7 China
7.1 China Transitional Cell Cancer Therapeutics Market Size (2014-2019)
7.2 Transitional Cell Cancer Therapeutics Key Players in China
7.3 China Transitional Cell Cancer Therapeutics Market Size by Type
7.4 China Transitional Cell Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Transitional Cell Cancer Therapeutics Market Size (2014-2019)
8.2 Transitional Cell Cancer Therapeutics Key Players in Japan
8.3 Japan Transitional Cell Cancer Therapeutics Market Size by Type
8.4 Japan Transitional Cell Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Transitional Cell Cancer Therapeutics Market Size (2014-2019)
9.2 Transitional Cell Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Transitional Cell Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Transitional Cell Cancer Therapeutics Market Size by Application

10 India
10.1 India Transitional Cell Cancer Therapeutics Market Size (2014-2019)
10.2 Transitional Cell Cancer Therapeutics Key Players in India
10.3 India Transitional Cell Cancer Therapeutics Market Size by Type
10.4 India Transitional Cell Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Transitional Cell Cancer Therapeutics Market Size (2014-2019)
11.2 Transitional Cell Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Transitional Cell Cancer Therapeutics Market Size by Type
11.4 Central & South America Transitional Cell Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Transitional Cell Cancer Therapeutics Introduction
12.1.4 AstraZeneca Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Transitional Cell Cancer Therapeutics Introduction
12.2.4 Roche Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Transitional Cell Cancer Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Transitional Cell Cancer Therapeutics Introduction
12.4.4 Pfizer Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Exelixis
12.5.1 Exelixis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Transitional Cell Cancer Therapeutics Introduction
12.5.4 Exelixis Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)
12.5.5 Exelixis Recent Development
12.6 Eisai
12.6.1 Eisai Company Details
12.6.2 Company Description and Business Overview
12.6.3 Transitional Cell Cancer Therapeutics Introduction
12.6.4 Eisai Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)
12.6.5 Eisai Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Transitional Cell Cancer Therapeutics Introduction
12.7.4 Merck Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Company Details
12.8.2 Company Description and Business Overview
12.8.3 Transitional Cell Cancer Therapeutics Introduction
12.8.4 Eli Lilly Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)
12.8.5 Eli Lilly Recent Development
12.9 Celgene
12.9.1 Celgene Company Details
12.9.2 Company Description and Business Overview
12.9.3 Transitional Cell Cancer Therapeutics Introduction
12.9.4 Celgene Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)
12.9.5 Celgene Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Transitional Cell Cancer Therapeutics Key Market Segments
Table Key Players Transitional Cell Cancer Therapeutics Covered
Table Global Transitional Cell Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Transitional Cell Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure Transurethral Resection Of Bladder Tumor Figures
Table Key Players of Transurethral Resection Of Bladder Tumor
Figure Cystectomy Figures
Table Key Players of Cystectomy
Figure Urinary Diversion Figures
Table Key Players of Urinary Diversion
Table Global Transitional Cell Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Cancer Research Institutes Case Studies
Figure Multispecialty Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Transitional Cell Cancer Therapeutics Report Years Considered
Table Global Transitional Cell Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Transitional Cell Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Transitional Cell Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Transitional Cell Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Transitional Cell Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Transitional Cell Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Transitional Cell Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Transitional Cell Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Transitional Cell Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Transitional Cell Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Transitional Cell Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Transitional Cell Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Transitional Cell Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Transitional Cell Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Transitional Cell Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Transitional Cell Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Transitional Cell Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Transitional Cell Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Transitional Cell Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Transitional Cell Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Transitional Cell Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Transitional Cell Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Transitional Cell Cancer Therapeutics Market Share (2018-2019)
Table United States Transitional Cell Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Transitional Cell Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Transitional Cell Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Transitional Cell Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Transitional Cell Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Transitional Cell Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Transitional Cell Cancer Therapeutics Market Share (2018-2019)
Table Europe Transitional Cell Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Transitional Cell Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Transitional Cell Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Transitional Cell Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Transitional Cell Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Transitional Cell Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Transitional Cell Cancer Therapeutics Market Share (2018-2019)
Table China Transitional Cell Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Transitional Cell Cancer Therapeutics Market Share by Type (2014-2019)
Table China Transitional Cell Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Transitional Cell Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Transitional Cell Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Transitional Cell Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Transitional Cell Cancer Therapeutics Market Share (2018-2019)
Table Japan Transitional Cell Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Transitional Cell Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Transitional Cell Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Transitional Cell Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Transitional Cell Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Transitional Cell Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Transitional Cell Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Transitional Cell Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Transitional Cell Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Transitional Cell Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Transitional Cell Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Transitional Cell Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Transitional Cell Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Transitional Cell Cancer Therapeutics Market Share (2018-2019)
Table India Transitional Cell Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Transitional Cell Cancer Therapeutics Market Share by Type (2014-2019)
Table India Transitional Cell Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Transitional Cell Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Transitional Cell Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Transitional Cell Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Transitional Cell Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Transitional Cell Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Transitional Cell Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Transitional Cell Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Transitional Cell Cancer Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Transitional Cell Cancer Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Roche Company Details
Table Roche Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Transitional Cell Cancer Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Transitional Cell Cancer Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Transitional Cell Cancer Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Exelixis Company Details
Table Exelixis Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Exelixis Revenue Growth Rate in Transitional Cell Cancer Therapeutics Business (2014-2019)
Table Exelixis Recent Development
Table Eisai Company Details
Table Eisai Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Transitional Cell Cancer Therapeutics Business (2014-2019)
Table Eisai Recent Development
Table Merck Company Details
Table Merck Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Transitional Cell Cancer Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Transitional Cell Cancer Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Celgene Company Details
Table Celgene Revenue in Transitional Cell Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Transitional Cell Cancer Therapeutics Business (2014-2019)
Table Celgene Recent Development
Table Global Transitional Cell Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Transitional Cell Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Transitional Cell Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Transitional Cell Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Transitional Cell Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Transitional Cell Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Transitional Cell Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Transitional Cell Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Transitional Cell Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Transitional Cell Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Transitional Cell Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Transitional Cell Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Transitional Cell Cancer Therapeutics Market Size by Product in 2025
Table Global Transitional Cell Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Transitional Cell Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Transitional Cell Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の樹状細胞がんワクチン市場：市場規模・現状・予測

Global Dendritic Cell Cancer Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7076 2019年6月14日 108Pages
当資料は、樹状細胞がんワクチンのグローバル市場について調査・分析したレポートで、種類別（CreaVax、Sipuleucel-T（プロバンジ）、その他）、用途別（小児、大人）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の肺がんの診断と治療市場：市場規模・現状・予測

Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7483 2019年6月14日 103Pages
当資料は、肺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（非小細胞肺がん、小細胞肺がん）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の腎臓がん市場：市場規模・現状・予測

Global Kidney Cancer Market Size, Status and Forecast 2019-2025
QYR9N7423 2019年6月14日 94Pages
当資料は、腎臓がんのグローバル市場について調査・分析したレポートで、種類別（腎細胞がん（RCC）、移行上皮がん（TCC））、用途別（手術、免疫療法、化学療法、放射線療法）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...

世界の皮膚がんの診断と治療市場：市場規模・現状・予測

Global Skin Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N8050 2019年6月14日 104Pages
当資料は、皮膚がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（日光角化症（AK）、ベース細胞がん（BCC）、扁平上皮がん（SCC）、メラノーマ）、用途別（病院、がん研究センター、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、...

世界の膵がん治療市場：市場規模・現状・予測

Global Pancreatic Cancer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7757 2019年6月14日 99Pages
当資料は、膵がん治療のグローバル市場について調査・分析したレポートで、種類別（生物学、化学療法、ターゲット療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
<...

世界のペプチドベースのがん治療薬市場：市場規模・現状・予測

Global Peptide Based Cancer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7786 2019年6月14日 93Pages
当資料は、ペプチドベースのがん治療薬のグローバル市場について調査・分析したレポートで、種類別（ゴセレリン、ボルテゾミブ、ロイプロレリン、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報...

世界の中咽頭がんの診断と治療法市場：市場規模・現状・予測

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7722 2019年6月14日 99Pages
当資料は、中咽頭がんの診断と治療法のグローバル市場について調査・分析したレポートで、種類別（内視鏡検査、生検、イメージング）、用途別（病院、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の幹細胞再構成市場：市場規模・現状・予測

Global Stem Cell Reconstructive Market Size, Status and Forecast 2019-2025
QYR9N8083 2019年6月14日 95Pages
当資料は、幹細胞再構成のグローバル市場について調査・分析したレポートで、種類別（胚性幹細胞、成体幹細胞）、用途別（病院、研究機関、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・...

世界の再生細胞市場：市場規模・現状・予測

Global Regenerative Cell Market Size, Status and Forecast 2019-2025
QYR9N7946 2019年6月14日 95Pages
当資料は、再生細胞のグローバル市場について調査・分析したレポートで、種類別（同種異系、自家）、用途別（筋骨格系疾患、皮膚科および創傷、心血管疾患、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の非侵襲がん診断市場：市場規模・現状・予測

Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2019-2025
QYR9N7685 2019年6月14日 91Pages
当資料は、非侵襲がん診断のグローバル市場について調査・分析したレポートで、種類別（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別（血液がん、固形腫瘍、乳がん、肺癌、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界の樹状細胞がんワクチン市場：市場規模・現状・予測 Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine…
世界の皮膚がんの診断と治療市場：市場規模・現状・予測 Skin cancer is the uncontrolled development of anomalous skin cells.The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. In 2018, the global Skin Cancer Diagnosis and Therapeutics market size was xx million …
世界の肺がんの診断と治療市場：市場規模・現状・予測 Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the g…
世界の腎臓がん市場：市場規模・現状・予測 Kidney cancer is a type of cancer that starts in the cells in the kidney.The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatm…
世界の膵がん治療市場：市場規模・現状・予測 Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …